Results 221 to 230 of about 4,145,262 (262)

Biologically Optimized Radiation Therapy

Acta Oncologica, 2001
Advanced treatment optimization is possible using quantitative radiobiological dose response models. Although all present models are necessarily linked to a certain degree of uncertainty, this will only have a small influence on the relative shape of the resultant optimal dose distribution.
A, Brahme, J, Nilsson, D, Belkic
openaire   +2 more sources

Optimizing intraoperative fluid therapy

Current Opinion in Anaesthesiology, 2003
Correcting the fluid status of the surgical patient is an integral part of good anaesthetic practice. There have been few areas in anaesthesia and perioperative medicine as controversial as fluid resuscitation. Uncertainties still exist as to what the best solution to give is, whether it be a colloid or a crystalloid, and how and when to give it.
Robert, Stephens, Monty, Mythen
openaire   +2 more sources

Pharmacodynamic optimization of warfarin therapy

Clinical Pharmacology and Therapeutics, 1994
Pharmacokinetic-pharmacodynamic information regarding warfarin is used to produce a predictive model based on the idea that pharmacodynamic variability is more important than pharmacokinetic variability in the overall dose-response variability to warfarin.
openaire   +4 more sources

Optimization of Cardiac Resynchronization Therapy

Echocardiography, 2008
Cardiac resynchronization is now an accepted and widespread therapy for patients with left ventricular (LV) systolic dysfunction. However, there are still a significant number of patients that do not appear to gain benefit, and this is currently the focus of a great deal of research.
Amit, Bhan, Stamatis, Kapetanakis, Mark J, Monaghan   +2 more
openaire   +2 more sources

Optimizing the Alliance in Couple Therapy

Family Process, 2004
The complexity of the relation between alliance and outcome in couple therapy was investigated in a study of 47 couples in brief therapy. Self‐rated alliance was measured after the first and third sessions using the couple version of the Working Alliance Inventory.
Dianne, Symonds, Adam O, Horvath
openaire   +2 more sources

Optimizing platelet transfusion therapy

Blood Reviews, 2004
Platelet transfusions are widely used. Prophylactic transfusions are employed in severely thrombocytopenic patients without evidence of bleeding, but no randomized trial data prove the safety or efficacy of this approach. Randomized trials have demonstrated the equivalence of transfusion triggers of 10,000 and 20,000/microl for prophylactic ...
Joanna Mary, Heal, Neil, Blumberg
openaire   +2 more sources

Optimal antimicrobial therapy for sepsis

American Journal of Health-System Pharmacy, 2002
The selection of appropriate antimicrobial therapy for patients with sepsis is discussed. Antimicrobial selection is based on the most likely source of infection, the most common pathogens at that site, knowledge of antimicrobial susceptibility patterns in the local community and institution, and host factors.
openaire   +2 more sources

Optimizing Therapy for MRSA Pneumonia

Seminars in Respiratory and Critical Care Medicine, 2007
With its remarkable armamentarium of resistance and virulence factors, Staphylococcus aureus has emerged as a dominant pathogen causing pneumonia of all classifications. Rates of methicillin resistance are increasing as clinicians struggle to find ways to prevent the acquisition of methicillin-resistant Staphylococcus aureus (MRSA) and to effectively ...
Lee P, Skrupky, Scott T, Micek, Marin H, Kollef   +2 more
openaire   +2 more sources

Optimal therapy for enterococcal endocarditis

The American Journal of Medicine, 1984
Enterococcal endocarditis accounts for an increasing proportion of cases of endocarditis in recent years. The combination of a penicillin and an aminoglycoside has become an accepted standard of treatment for this disease. However, the optimal choice of antibiotics, duration of therapy, and timing of surgical intervention remain controversial.
J, Herzstein, J L, Ryan, R J, Mangi, T P, Greco, V T, Andriole   +4 more
openaire   +2 more sources

Optimizing transdermal drug therapy

American Journal of Health-System Pharmacy, 2008
The pharmacokinetics, benefits, risks, and future of transdermal drug products are reviewed.Transdermal drug delivery capitalizes on an attractive route of drug delivery, as it avoids the need for painful i.v. drug administration, i.v. site access, and syringe disposal and is an option for drug delivery to patients who are unable to swallow oral ...
Amanda M, Ball, Kelly M, Smith
openaire   +2 more sources